Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
Summit Therapeutics was founded in 2003 and is based in Oxford, United Kingdom. The company has multiple subsidiaries worldwide, including those in the US, Europe, and Canada. The company's focus is on discovering, developing, and ultimately commercialising small molecule medicines for the treatment of infectious diseases and other conditions with unmet needs. The company’s lead product is ridinilazole, which is in clinical development to treat Clostridioides difficile infection.
